Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Imaging of Plaque Vulnerability Using 18F-choline PET-MRI in Carotid Artery Atherosclerosis Patients

NCT02640313 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT02640313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02640313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Imaging of Plaque Vulnerability Using 18F-choline PET-MRI in Carotid Artery Atherosclerosis Patients
Lead sponsor
Maastricht University Medical Center
Phase
Phase 3
Overall status
Unknown status
Start date
December 31, 2015
Completion date
March 1, 2024
Enrollment
14 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

plaque, atherosclerotic